$8.62
-0.21-2.41%
After Hours: Mar 21, 4:25 AM EDT
Comments
Loading...
Pharming Stock Guidance | NASDAQ:PHAR | Benzinga
Pharming issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | PHAR | Pharming | FY | 2025 | — | — | — | $315.00M | $335.00M | $299.76M | Get Alert |
| 10/24/2024 | PHAR | Pharming | FY | 2024 | — | — | — | $280.00M | $295.00M | — | Get Alert |
| 08/01/2024 | PHAR | Pharming | FY | 2024 | — | — | — | $280.00M | $295.00M | — | Get Alert |
| 05/08/2024 | PHAR | Pharming | FY | 2024 | — | — | — | $280.00M | $295.00M | — | Get Alert |
| 01/08/2024 | PHAR | Pharming | FY | 2023 | — | — | — | $245.00M | $245.00M | — | Get Alert |
FAQ
What is the most recent guidance for Pharming (PHAR)?
There have been no specific sales or earnings guidance reported for Pharming in recent months.
Browse guidance and forecast on all stocks.